45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets.
72 Biggest Movers From Yesterday
Gainers
Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
Immunome’s COVID-19 Antibody Neutralizes Two Variant Strains In Animal Studies
Immunome Inc’s (NASDAQ:IMNM) three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against SARS-CoV-2 Lambda (C.37) and Delta AY.1/2 (Delta…
Immunome Says Its IMM-BCP-01 ‘Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing’
-IMM-BCP-01 already shown to neutralize all other Centers for Disease Control (CDC) variants of concern in pre-clinical testing-
Immunome, Inc. (NASDAQ:IMNM), a biopharmaceutical company that utilizes its human
Immunome Q2 EPS $(0.46) Misses $(0.39) Estimate
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.39) by 17.95 percent.
38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to purchase Chembio's DPP SARS-CoV-2 Antigen tests for delivery during 2021.
28 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed registration for $60 million common stock offering.
62 Biggest Movers From Yesterday
Gainers
NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment of fibromyalgia with its wearable neurostimulation technology.